NCT00955773 A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects Status COMPLETED Phase PHASE1
NCT00954291 An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects Status UNKNOWN Phase N/A
NCT00952107 Objective Flap Assessment During Reconstructive Surgery Status COMPLETED Phase EARLY_PHASE1
NCT00949052 Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer Status TERMINATED Phase N/A
NCT00946803 A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms Status COMPLETED Phase NA
NCT00942968 Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer Status COMPLETED Phase PHASE4
NCT00942695 Energy Value of Macronutrients From Pistachio Nuts and Mechanisms of Nutrient Action Status COMPLETED Phase NA
NCT00940225 Study of Cabozantinib (XL184) in Adults With Advanced Malignancies Status COMPLETED Phase PHASE2
NCT00937664 Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine Status TERMINATED Phase PHASE1
NCT00930085 Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients Status COMPLETED Phase NA
NCT00928382 A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression Status COMPLETED Phase N/A
NCT00927823 A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients Status COMPLETED Phase PHASE1
NCT00925899 Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer Status COMPLETED Phase PHASE2/PHASE3